Xromi

Xromi is a drug used to prevent complications caused by blood vessel blockages in children aged between 9 months and 2 years, resulting from sickle cell anemia. This medication reduces painful crises and the need for hospitalization.

It is a Hydroxycarbamide solution for treating sickle cell anemia in a formulation specifically designed for children, belonging to the group of oncolytics.

• One bottle containing 150 ml of Hydroxycarbamide 100 mg/ml, with precise dosage information for

  children.

• A bottle adapter with 2 dosing syringes (1 ml and 5 ml).

Xromi 100 mg/ml solution is registered under the number EU/1/19/1366.

Xromi is a prescription medication